Hospital Universitario 12 de Octubre clinical trials
Hospital Universitario 12 de Octubre is the lead sponsor of 8 current clinical trials in our Spain, Italy, Sweden and EU (CTIS) registers. 5 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Cannabidiol. The most-studied condition is Atrial Fibrillation.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Hospital Universitario 12 de Octubre
7 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum
NCT07095829 · ClinicalTrials.gov ↗ · Pulmonary Atresia With Intact Ventricular Septum, Congenital Heart Disease, Fetal Cardiac Disorder
|
Observational | Recruiting | 2024-02 | Spain, Sweden |
|
Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
NCT06698159 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Atrial Fibrillation (Paroxysmal)
|
Not applicable | Recruiting | 2024-11 | Spain, Italy |
|
Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
NCT06896266 · ClinicalTrials.gov ↗ · Arrhythmia, Cardiomyopathy, Arrhythmia-induced Cardiomyopathy (AiCM)
|
Observational | Recruiting | 2024-12 | Spain |
|
Implementation of Biomarker-Based Care for mTBI - IMPACTS-BRAINI Study
NCT07311486 · ClinicalTrials.gov ↗ · Mild Traumatic Brain Injury (mTBI)
|
Observational | Recruiting | 2025-07 | Spain |
|
Clinical Trial for the Evaluation of Customized 3D Printed NIV Nasal Masks in Premature Infants
NCT06224816 · ClinicalTrials.gov ↗ · Premature Lungs
|
Not applicable | Recruiting | 2024-04 | Spain |
|
Intraventricular Hemorrhage in Kangaroo Care vs. Incubator Care
NCT07473882 · ClinicalTrials.gov ↗ · Kangaroo Care, Premature Infant, IVH- Intraventricular Hemorrhage
|
Not applicable | Not yet open | 2027-01 | Spain |
|
AI-Assisted Remote Monitoring for Patients With or at Risk of Malignant Bowel Obstruction
NCT07931989 · ClinicalTrials.gov ↗ · Malignant Bowel Obstruction, Intestinal Obstruction
|
Not applicable | Not yet open | 2026-11 | Spain |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Hospital Universitario 12 de Octubre in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System with Hospital Universitario 12 de Octubre as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
Phase II, Placebo-controlled trial of Cannabidiol for the treatment of alcohol dependence (PLACONCANALDE)
2023-504439-42-03 · CTIS ↗ · Behavioral Disciplines and Activities
Drug: Cannabidiol |
Phase 2 | Authorised | Spain |
Drugs in Hospital Universitario 12 de Octubre trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Hospital Universitario 12 de Octubre trials
15 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Spain | 7 | 5 |
| Clinical trials in Italy | 1 | 1 |
| Clinical trials in Sweden | 1 | 1 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Atrial Fibrillation
Sponsors with the most current trials registered for this condition.
Questions about Hospital Universitario 12 de Octubre trials
How many clinical trials does Hospital Universitario 12 de Octubre sponsor?
Hospital Universitario 12 de Octubre is the lead sponsor of 7 current trials on ClinicalTrials.gov in our Spain, Italy and Sweden registers, and 1 authorised or ongoing trial in the EU register (CTIS), as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.
Are Hospital Universitario 12 de Octubre trials recruiting?
Yes. 5 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Hospital Universitario 12 de Octubre testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Cannabidiol (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.